EGFR and oropharynx cancer: Interestingly, two of the phase III clinical trials investigating the combination of anti-EGFR therapy with radiotherapy compared to the standard treatment with chemo-radiotherapy for HPV-positive oropharyngeal cancer patients, the RTOG 1026 and the DE-ESCALaTE study, have been recently presented.